Risk of Frailty Associated With Changes in Oral Function

Share this content:
Risk of Frailty Associated With Changes in Oral Function
Risk of Frailty Associated With Changes in Oral Function

FRIDAY, Sept. 30, 2016 (HealthDay News) -- Aging is tied to changes in oral function, according to a study published online Sept. 22 in the Journal of the American Geriatrics Society.

Yutaka Watanabe, D.D.S., Ph.D., from the Tokyo Metropolitan Institute of Gerontology, and colleagues conducted detailed physical testing to classify elderly adults (≥65 years) by frailty (mobility, strength, endurance, physical activity, and nutrition): robust, prefrail, or frail. Additionally, the numbers of present teeth and functional teeth were counted, plus measurements of occlusal force, masseter muscle thickness, and oral diadochokinesis (ODK) rate.

The researchers found that the frail group had significantly fewer teeth present (women aged ≥70), lower occlusal force (women aged ≥70; men aged ≥80), lower masseter muscle thickness, and lower ODK rate, compared to the robust group. Multivariate analysis indicated that frailty was also significantly associated with age, Geriatric Depression Scale score, skeletal muscle mass index, Mini-Mental State Examination score, hypertension, diabetes mellitus, albumin and triglyceride levels, and oral function.

"The risk of frailty was associated with lower occlusal force, masseter muscle thickness, and ODK rate," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »